Cancer stem cells: A revisitation of the anaplasia concept

Advances in Cancer Stem Cell Biology

Volumn , Issue , 2013, Pages 1-16

  Scatena, Roberto ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872202289     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-0809-3_1     Document Type: Chapter

References (56)

1. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-88
2. Allen M, Louise Jones J. (2011). Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J Pathol. 223: 162-76
3. Anderson K, Lutz C, van Delft FW, et al. (2011). Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 469: 356-61
4. Barbie DA, Hahn WC, Pelman DS. (2008). Destabilization of cancer genome. In: Devita, Hellman & Rosenberg's Cancer: Principles & Practice of Oncology 8th Ed. DeVita VT; Lawrence TS.; Rosenberg SA (Eds). Lippincott Williams & Wilkins. Philadelphia, PA, USA
5. Beckman RA (2010). Efficiency of carcinogenesis: is the mutator phenotype inevitable? Semin Cancer Biol. 20: 340-52
6. Bonnet D, Dick JE. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-7
7. Brégeon D, Doetsch PW. (2011). Transcriptional mutagenesis: causes and involvement in tumour development. Nat Rev Cancer 11: 218-27
8. Bristow RG, Hill RP. (2008). Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 8: 180-92
9. Calabrese C, Poppleton H, Kocak M, et al. (2007). A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69-82
10. Clarke MF, Dick JE, Dirks PB, et al. (2006) Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res.66: 9339-9344
11. Clevers H. (2011). The cancer stem cell: premises, promises and challenges. Nat Med. 17: 313-9
12. Collins AT, Berry PA, Hyde C. (2005). Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65: 10946-51
13. Conway AE, Lindgren A, Galic Z, et al. (2009). A self-renewal program controls the expansion of genetically unstable cancer stem cells in pluripotent stem cell-derived tumors. Stem Cells. 27: 18-28
14. Dayal D, Martin SM, Owens KM, et al. (2009). Mitochondrial complex II dysfunction can contribute significantly to genomic instability after exposure to ionizing radiation. Radiat Res. 172: 737-45
15. Dick JE. (2008). Stem cell concepts renew cancer research. Blood 112: 4793-807
16. Gilbertson RJ and Rich JN. (2007). Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nature Rev. Cancer 7: 733-736
17. Greaves M (2010). Cancer stem cells: back to Darwin? Semin Cancer Biol. 20: 65-70
18. Gupta PB, Chaffer CL, Weinberg RA. (2009). Cancer stem cells: mirage or reality? Nat Med. 15: 1010-2
19. Jamieson CH, Ailles LE, Dylla SJ, et al. (2004). Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med. 351: 657-67
20. Janic A, Mendizabal L, Llamazares S, et al. (2010). Ectopic expression of germline genes drives malignant brain tumor growth in Drosophila. Science. 330: 1824-7
21. LaBarge MA. (2010). The difficulty of targeting cancer stem cell niches. Clin Cancer Res. 16: 3121-9
22. Leder K, Holland EC, Michor F. (2010). The therapeutic implications of plasticity of the cancer stem cell phenotype. PLoS One. 5: e14366
23. Li C, Heidt DG, Dalerba P, et al. (2007). Identification of pancreatic cancer stem cells. Cancer Res. 67: 1030-7
24. Liu W, Laitinen S, Khan S, et al. (2009). Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med. 15: 559-65
25. Liu C, Kelnar K, Liu B, et al. (2011). The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 17: 211-5
26. Maenhaut C, Dumont J E, Roger P Pand van Staveren W C G. (2010). Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis. Carcinogenesis 31: 149-158
27. Mani SA, Guo W, Liao MJ, et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133: 704-15
28. Notta F, Mullighan CG, Wang JC, et al. (2011). Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells. Nature 469: 362-7
29. O'Brien CA, Pollett A, Gallinger S, Dick JE. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-10
30. Park SY, et al. (2010). Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J Clin Invest.120: 636-44
31. Perera S, Bapat B. (2007). Genetic Instability in Cancer. Atlas Genet Cytogenet Oncol Haematol. January 2007. URL: http://AtlasGeneticsOncology.org/Deep/GenetInstabilityCancerID20056.html
32. Pierce GB, Speers WC. (1988). Tumors as caricatures of the process of tissue renewal: prospects for therapy by directing differentiation. Cancer Res 48: 1996-2004
33. Quintana E, Shackleton M, Sabel MS, et al. (2008). Efficient tumour formation by single human melanoma cells. Nature 456: 593-8
34. Rapp UR, Ceteci F, Schreck R. (2008). Oncogene-induced plasticity and cancer stem cells. Cell Cycle. 7: 45-51
35. Raynaud CM, Sabatier L, Philipot O, et al. (2008). Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process. Crit Rev Oncol Hematol. 66: 99-117
36. Reya T Morrison SJ, Clarke MF, Weissman IL. (2001). Stem cells, cancer, and cancer stem cells. Nature 414: 105-11
37. Ricci-Vitiani L, Pallini R, Biffoni M, et al. (2010). Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468: 824-8
38. Roesch A, Fukunaga-Kalabis M, Schmidt EC, et al. (2010). A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 141: 583-94
39. Rosen JM, Jordan CT. (2009). The increasing complexity of the cancer stem cell paradigm. Science 324: 1670-3
40. Scatena R, Bottoni P, Giardina B. (2008). Modulation of cancer cell line differentiation: A neglected proteomic analysis with potential implications in pathophysiology, diagnosis, prognosis, and therapy of cancer. Proteomics Clin Appl. 2: 229-37
41. Scatena R, Bottoni P, Pontoglio A, Giardina B. (2010). Revisiting the Warburg effect in cancer cells with proteomics. The emergence of new approaches to diagnosis, prognosis and therapy. Proteomics Clin Appl. 4: 143-58
42. Scatena R, Bottoni P, Pontoglio A, Giardina B. (2011). Cancer stem cells: the development of new cancer therapeutics. Expert Opin Biol Ther. 11: 875-92
43. Sell S, Leffert HL. (2008). Liver cancer stem cells. J Clin Oncol. 26: 2800-5
44. Singh SK, Clarke ID, Terasaki M. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Res. 63: 5821-8
45. Sodir NM, Swigart LB, Karnezis AN, et al. (2011). Endogenous Myc maintains the tumor microenvironment. Genes Dev. 25: 907-16
46. Stricker TP, Kumar V. Neoplasia. (2010). In: Robbins and Cotran Pathologic Basis of Disease 8th Ed. Kumar V, Abbas AK, Fausto N, Aster JC (Eds) Saunders, Philadelphia
47. Tili E, Michaille JJ, Wernicke D. (2011) . Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc Natl Acad Sci USA. 108: 4908-13
48. Valeri N, Gasparini P, Fabbri M. (2010). Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci USA. 107: 6982-7
49. Visvader JE and Lindeman GJ. (2008).Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nature Rev. Cancer 8: 755-768
50. Visvader JE. (2011). Cells of origin in cancer. Nature. 469: 314-22
51. Von Hoff DD, LoRusso PM, Rudin CM, et al. (2009). Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med. 361: 1164-72
52. Yauch RL, Dijkgraaf GJ, Alicke B, et al. (2009). Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326: 572-4
53. Wang JCY, Dick JE. Cancer Stem Cells. (2008) In: Devita, Hellman & Rosenberg's Cancer: Principles & Practice of Oncology 8th Ed. DeVita VT; Lawrence TS.; Rosenberg SA (Eds). Lippincott Williams & Wilkins. Philadelphia, PA, USA, 135-143
54. Wang R, Chadalavada K, Wilshire J, et al. (2010). Glioblastoma stem-like cells give rise to tumour endothelium. Nature. 468: 829-33
55. Woodward WA, Sulman EP. (2008). Cancer stem cells: markers or biomarkers? Cancer Metastasis Rev. 27: 459-70
56. Zhou BB, Zhang H, Damelin M, et al. (2009). Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov. 8: 806-23